Latent membrane protein 2A (LMP-2A) is expressed in Epstein-Barr virus transformed B lymphocytes in vitro and has been detected in various types of EBVassociated malignancies. LMP-2A interferes with membrane signal transduction through phosphorylation of its hydrophilic N-terminal domain and binding of the cellular tyrosine kinases encoded byfvn and lyn. In vitro, the domain can block calcium influx and participate in signal transduction inducing cytokine production. These two activities are differently affected by site-directed mutagenesis of potentially phosphorylated amino acid residues. Several potential tyrosine protein kinase recognition motifs have been identified including an antigen recognition motif (ARAM). ARAMs are activated by tyrosine phosphorylation that enables binding of tyrosine protein kinases such as lyn and fvn. To assess the importance of potential sequence variation in natural EBV infection and in tumourigenesis, the sequence of the LMP-2A N-terminal domain was determined in 28 EBV isolates, including 14 fresh tumour isolates.
Latent membrane protein 2A (LMP-2A) is expressed in Epstein-Barr virus transformed B lymphocytes in vitro and has been detected in various types of EBVassociated malignancies. LMP-2A interferes with membrane signal transduction through phosphorylation of its hydrophilic N-terminal domain and binding of the cellular tyrosine kinases encoded byfvn and lyn. In vitro, the domain can block calcium influx and participate in signal transduction inducing cytokine production. These two activities are differently affected by site-directed mutagenesis of potentially phosphorylated amino acid residues. Several potential tyrosine protein kinase recognition motifs have been identified including an antigen recognition motif (ARAM). ARAMs are activated by tyrosine phosphorylation that enables binding of tyrosine protein kinases such as lyn and fvn. To assess the importance of potential sequence variation in natural EBV infection and in tumourigenesis, the sequence of the LMP-2A N-terminal domain was determined in 28 EBV isolates, including 14 fresh tumour isolates.
Comparison of the corresponding sequences with the prototype B95 strain indicates that LMP-2 is generally conserved with a few base pair changes resulting in conservative amino acid changes in an occasional isolate. However, five single-base loci were frequently mutated, resulting in three patterns of sequence polymorphism in exon 1 of LMP-2A. The patterns did not segregate with EBV Type 1 or Type 2 and were detected in both lymphoid and epithelial tissues. Four of the most frequent mutations at loci 166627, 166750, 166796 and 166805 (codons 23, 63, 79 and 82) could potentially affect tyrosine protein kinase binding motifs. The pivotal tyrosines (codons 74 and 85) and leucines (codons 77 and 88) of the LMP-2 ARAM were not affected in any of the isolates, suggesting that ARAM function is important for EBV infection in vivo. However, the interspacing positions 79 and 82 were distinct in more than 50% of the isolates. These prevalent polymorphisms could influence interaction of the LMP-2 cytoplasmic domain with specific cellular ligand proteins.
Epstein-Barr virus (EBV) encodes two integral membrane proteins, latent membrane proteins (LMPs) 1 and 2 (Kieff & Liebowitz, 1990) . There are two forms of LMP-2, LMP-2A and -2B, that are encoded by two transcripts which are spliced across the terminal repeats of the EBV DNA (Laux et al., 1988; Sample et al., 1989) . Therefore, their transcription requires episomal forms of the viral genome or rare integrative events (Hurley et al., 1991) . Each transcript results from the alternative splicing of a unique 5' exon 1, located at the right-end of the genome, while exons 2 to 9, located at the left-end of the genome, are common to both species. The LMP-2A 5' first exon (368 bp) encodes an N-terminal hydrophilic, intracytoplasmic domain (119 aa) while the LMP-2B first exon (154bp) is non-coding. The eight exons common to LMP-2A and -2B encode a highly hydro-* Author for correspondence. Fax +19199663015. e-mail nrt@med.unc.edu phobic transmembrane domain (1140 coding nucleotides; 378 aa) (Kieff & Liebowitz, 1990; Rabson et al., 1982) .
The LMP-2A and -2B proteins are known to be expressed in lymphoblastoid and Burkitt's lymphoma cell lines (Frech et al., 1990; Longnecker & Kieff, 1990 ). The LMP-2 genes are consistently transcribed in nasopharyngeal carcinomas (NPC) and LMP-2A transcripts have also been detected in EBV-positive uncultured peripheral blood lymphocytes (Brooks et al., 1992; Busson et al., 1992; Qu & Rowe, 1992) . The sequence of two overlapping cDNAs representative of the entire LMP-2A coding sequence was determined in C15, an NPC established in nude mice (Busson et al., 1988 . When compared with the B95 sequence, exons 2 to 9 were highly conserved; on a segment of 1140 bp, five mutations were detected with only one resulting in a significant change, at codon 126, with the replacement of a leucine by a proline. In contrast, nine mutations were 0001-2626 © 1995 SGM detected in the 368 bp exon 1A, with four significant changes for codons 23, 63, 64 and 82. The same codons were also altered in a partial cDNA derived from another transplanted NPC, C17 .
In this study, the prevalence of these codon changes was determined in additional EBV strains from infected tissues and cell lines. Twenty-eight EBV isolates were analysed including 18 turnout isolates and 10 from permanent cell lines. The C15 and C17 transplanted NPCs, for which the exon 1A sequences were previously reported, were also included in this comparison.
There are two types of EBV (Type 1 and 2), which are distinguished by divergent sequences in the Epstein-Barr nuclear antigen (EBNA) -2 and -3 genes (Sample et al., 1990; Zimber et al., 1986) . In addition, particular strains have been identified on the basis of several restriction enzyme fragment polymorphisms (RFP) Hu et al., 1991; Lung et al., 1990) . These studies revealed that the majority of NPC specimens from China or Malaysia were EBV Type 1 with several RFPs mapping to the right-end of the genome including the loss of a BamHI site at the W1/I1 junction and the loss of an XhoI site in the BamHI N fragment. NPC specimens from the Mediterranean area were also EBV Type 1 but lacked the distinctive RFPs of the Chinese isolates, although a subset of these were distinguished by an RFP mapping at the left-end of the genome within the BamHI H fragment. Interestingly, NPCs from Alaskan Eskimoes contained EBV Type 2 which was marked by the same RFPs as the Chinese strain. NPCs from American Caucasians frequently had the polymorphisms of the right-end or of the left-end of the genome and sometimes both of them together .
The EBV type and strain variation have been previously characterized for many of the isolates analysed in this study . The EBV type was determined by EBNA-2 sequence divergence as Type 1 or Type 2 (Zimber et al., 1986) . The strains which were marked by the RFPs detected in the Chinese and Alaskan isolates are designated Type 1-or Type 2-CH. Thirteen samples of NPC were analysed. The eight NPC biopsies include N10 (Egypt, Type 1), Bat (continental USA, Type 2-CH), Liv (Alaska, Type 2-CH), L2 (China, Type 2 without the CH RFPs), D3 (China, Type 1-CH), D6 (China, Type 1-CH), Si (Malaysia, Type 1-CH) and Chu (Malaysia, Type 1-CH). The four NPCs serially transplanted in nude mice included C15 (Morocco, Type 1), C17 (France, Type 1), C18 (Algeria, Type 1) and C19 (Italy, Type 1) (Busson et al., 1988) . In addition, the exon 1A LMP-2 sequence was analysed in a lymphoid cell line, NAD + C15, established by co-cultivation of C 15 NPC cells with lymphocytes from an EBV-negative donor. The identity of the EBV strain in the NAD + C15 cell line with that in the C15 tumour has been documented by comparison of the size of the variable EBNA1 protein (Ernberg et al., 1989) . A hybrid NPC cell line, NPC-KT, was derived from a Japanese NPC and contains a Type 1-CH EBV genome (Japan, Type 1-CH) (Sato et al., 1989; Takimoto et al., 1984) .
Six lymphoma biopsy samples were analysed: four post-transplant lymphomas from the United States (Hen, Fay, T580 and T594) and two Burkitt's lymphoma (BL), BL6 (Central Africa) and Coop (continental USA/ Mediterranean Africa, Type 1). Eight BL cell lines were analysed, including two pairs of cell lines derived from the same tumours. The non-paired cell lines were W91 (Central Africa, Type 1), AG876 (Central Africa, Type 2), Akata (Japan, Type 1) and BL72 (Algeria, Type 1) (Heller et al., 1981; Takada & Ono, 1989; Zimber et al., 1986) . The paired cell lines included Jijoye and P3HR1 (Central Africa, Type 2) and Mutu I and Mutu III (Central Africa, Type 1) (Gregory et al., 1990; Zimber et al., 1986) . The P3HR1 cell line carries a non-transforming EBV strain which is a deletion mutant of the transforming parental cell line, Jijoye (Rabson et al., 1982) . Mutu I and Mutu III are two subclones of an early passage BL cell line which differ with regard to growth phenotype and EBV expression (Gregory et al., 1990) .
Three regions of sequences were determined. The exon 1A sequence, which is both transcribed and translated, was sequenced in all 28 isolates from the ATG codon to the exon 1-exon 2 junction (nucleotides 166561 to 166916). A non-coding segment extending into the adjacent intron from nucleotide 166917 to 167007 was sequenced in 27 samples excluding C15. Exon IB, which is also non-coding, was sequenced from nucleotides 169697 to 169900 in five isolates (Bat, C15, C17, W91 and AG876). Sequences were determined by the dideoxynucleotide termination method on two types of template; either denatured plasmid inserts obtained by PCR cloning and/or single strand DNAs obtained by asymmetric PCR Effert et al., 1992) .
The PA5'-PA3' primer pair was used for PCR amplification of exon 1A and a part of the adjacent intron; the PB5' PB3' pair was used to amplify exon lB. Each primer contained a 4 bp buffer sequence, a 6 bp restriction enzyme site and a 20 or 21 bp segment of the EBV genome, according to the sequence of the B95-8 prototype strain: PA5', ACAGGAATTCGTTTTGC-AGTCGCTGCTGCA (EcoRI site + the 166538-166557 segment of the EBV genome); PA3", GTAGTCTAGA-GACCTGTTGTCCCTGAGATG (XbaI site + 167020-167039); PB5', ACAGGAATTCAGGGGAA-GTAGAAAGCGTGTG (EcoRI site + 169676-169696); PB3', GTAGTCTAGATACGGTTACCCCACAGCC-TTG (XbaI site + 169913-169933).
All nucleotide variations were identified by com- Busson et al., 1992) . In contrast, base pair changes were infrequent in the short segment of the adjacent intron which was sequenced. In addition, consistent changes or clusters of changes which affected more than one isolate were not detected in exon 1B. For example, the cluster of changes Short communication in exon 1A was present in both the C15 and the C17 isolates, whereas the changes in exon 1B were not present in both isolates. One nucleotide change at 166627, in which the thymidine of B95 is replaced by guanine, was unusual in that it was detected in all EBV isolates except B95. This base pair substitution results in a non-conservative codon change in which tyrosine 23 is replaced by asparagine. The presence of a thymidine in B95 at this position was not only reported when the B95 sequence was first published but has also been confirmed in subsequent analyses of LMP-2A cDNAs from B95 (Laux et al., 1988; Sample et al., 1989) .
The other four loci, which were frequently mutated, distinguished three types of sequence variation in exon 1A. In 54% of the isolates (13/24) the nucleotides were altered at all four loci (Table 2, pattern A4). In 30 % (7/24) the nucleotide of the prototype sequence was retained at all four loci (pattern P4). In 16 % (4/24) there was only one altered site with a mutation at nucleotide 166805 (pattern PPAP).
Some of the BL and NPC isolates have been propagated for several years as cell lines or tumours in nude mice and could have acquired additional nucleotide polymorphisms during cultivation. To address this point, the exon 1A sequence was compared in three pairs of isolates derived from the same clinical specimens and propagated independently for several months or years. Within each pair the majority of nucleotide polymorphisms were identical although some mutations were unique to one of the pair. Interestingly, in all three pairs, both isolates have the same pattern in the four loci which are the most variable in isolates of distinct origin. This observation indicates that the A4, PPAP and P4 polymorphisms are not frequently affected by in vitro propagation and represent the original viral genotype. Therefore, each pair was considered as a single isolate.
There was no preferential association of the three patterns with either of the two EBV Types. Of 15 EBV Type 1 samples nine had the A4 (N10, Si, C15, C17, C18, C19, Coop, BL72 and Mutu), five had the P4 (D3, Chu, NPC-KT, W91 and Akata) and one (D6) had the PPAP patterns ( Table 2 ). The five EBV Type 2 samples split two, one and two into patterns A4 (Bat and L2), P4 (AG876) and PPAP (Liv, Jijoye), respectively.
Similarly, there was no consistent association of the three patterns with the polymorphic markers of the rightend of the genome which are detected in Chinese EBV Type 1 strains and Alaskan EBV Type 2 strains. One of the markers is the loss of an XhoI site within the LMP-1 gene at nucleotide 169423 which denotes strains with multiple consistent amino acid changes in LMP-1 Hu et al., 1991 ; W. E. Miller et al., 1994) . The XhoI polymorphism was known for 17 isolates. Of 10 samples which retained the XhoI site, seven were A4 (N10, L2, C15, C17, C18, C19 and Coop) and three were P4 (594, W91 and AG876). The seven samples without the XhoI site, split two, three and two into patterns A4 (Si and Bat), PPAP (D6, Hen and Liv) and P4 (D3 and Chu), respectively. Therefore the A4 polymorphism did not co-segregate with either EBV Type or strain variants presently identified by specific RFPs of the right-end of the genome.
Interestingly, the A4 marker was detected in all samples of Mediterranean origin, including five NPC samples (N10, C15, C17, C18 and C19), one BL biopsy (Coop) and one BL cell line (BL72). However, the A4 polymorphism was not unique to Mediterranean isolates and was also detected in three of eight Chinese and Alaskan NPCs (Si, L2 and Bat), two of four American post-transplant lymphomas (Fay and 580) and two of five BL biopsy specimens, and cell lines from Central Africa (BL6 and Mutu).
The significance of amino acid changes resulting from the nucleotide changes in exon 1A was assessed by a combination of two approaches. The amino acid changes were first scored on a mutation data matrix (MDM), which is based on the observed frequencies of amino acid substitutions in various sets of closely related peptide sequences (George et al., 1990) . LMP-2 mutations with a score higher or lower than 0 were classified as conservative or non-conservative, respectively. For mutations with a score of zero, the structural characteristics of variant amino acids were considered. For example, the mutation at codon 82 results in the substitution of proline for a charged amino acid, and was therefore classified as non-conservative. Based on these criteria, three out of five codons which were mutated in more than 50 % of the isolates were non-conservative changes (codons 23, 64 and 82). The functional impact of these alterations is potentially very interesting. Investigations with recombinant EBV strains have shown that LMP-2A is dispensable for lymphocyte immortalization (Longnecker et aL, 1993) . However, it potentially has a critical role counteracting the induction of the lytic cycle by surface immunoglobulin crosslinking. This inhibitory effect, which requires the presence of an intact intracytoplasmic domain, is apparently linked to a blockade of the calcium influx induced by immunoglobulin crosslinking N-terminus Fig. 1 . Numbered residues indicate all codon changes which resulted in amino acid substitutions for at least one isolate. Arrows denote nonconservative changes detected in more than 50 % of the isolates. Potential tyrosine protein kinase motifs are indicated with black circles. Numbers in parentheses signal the first and last residue of each motif and the pivotal leucine and tyrosine residues of the ARAM (residues 72-88.) (C. L. Miller et al., 1994) . Another biological activity of the LMP-2A cytoplasmic domain has been demonstrated in a murine model. When fused to the CD8 external and transmembrane segments, the cytoplasmic LMP-2A domain can transduce a signal inducing cytokine production. This signal is not accompanied by a blockade of calcium influx (Beaufils et al., 1993) .
At a molecular level, the cytoplasmic LMP-2A domain is known to be a substrate for tyrosine, serine and threonine phosphorylation. It binds several proteins in vivo, including the tyrosine protein kinases (TPK) of the src family, encoded by lyn and fyn (Longnecker et al., 1991; Burkhardt et al., 1992) .
Sequence comparisons have pointed to several motifs which are potential targets for phosphorylation and critical elements for signal transduction. Two motifs compatible with canonical sequences for serine/ threonine phosphorylation are detectable in the intracytoplasmic domain: SNEE (casein kinase II, aa 52-55) and SPR (protein kinase C, aa 102-104) (Kemp & Pearson, 1990; Sun et al., 1991) ; they are unaffected by any of the sequence variations identified in this study (Fig. 1) . This conservation may indicate that these motifs are important in EBV infection in vivo.
Two potential TPK motifs have been initially proposed: YDGGN (codons 23-27) and YED (codons 60-62) (Burkhardt et al., 1992) . As previously mentioned, tyrosine 23 is replaced by an asparagine in all isolates; therefore the existence of the YDGGN motif is unique to the B95 strain, indicating that tyrosine 23 is unlikely to contribute to recognition by TPKs. The YED motif is not directly affected by any mutation although significant coding changes are detected in close proximity. Proline 64 is mutated to asparagine in all 13 isolates with the A4 pattern; codon 63 is also affected by non-conservative mutations in five of them (CL2, C15, C17, Coop and Fay). These amino acid changes adjacent to the YED motif might affect recognition in different cellular contexts.
More recently, several investigators have focused their interest on an antigen recognition activation motif (ARAM) contained in the LMP-2A segment 72-88 (Beaufils et al., 1993; W. E. Miller et al., 1994) . ARAMs, also called antigen receptor homology 1 motifs, are approximately 20 bp long and contain two YXXL/I sequences spaced by seven or eight amino acids. They are present in the cytoplasmic domain of the proteins associated with the B and T cell antigen receptors. One similar motif is also contained in the envelope glycoprotein (gp30) of bovine leukaemia virus (BLV). ARAMS are activated by phosphorylation of the tyrosine residues, which subsequently mediates binding of TPKs like lyn, fyn and ZAP70 Weiss, 1993) .
Experimental evidence about the role of the LMP-2A ARAM has been obtained in the above cited murine model. Mutation of one of the pivotal tyrosines (74 or 85) abrogates the signal transducing activity of the CD8-LMP-2 chimeric molecule (Beaufils et al., 1993) . Interestingly the pivotal tyrosines (74 and 85) and leucines (77 and 88) were not affected by mutation in any of the 28 EBV isolates analysed here and are a likely site for tyrosine phosphorylation. The absolute conservation of the residues that are potentially essential for ARAM function suggests that the LMP-2A ARAM is important in EBV natural infection in vivo.
In contrast with the pivotal tyrosine and leucine residues, two spacing residues at position 79 and 82 were modified in more than 50 % isolates. Fig. 2 compares the ARAMs identified in BLV gp30, B95 and C15 LMP-2A (which has a typical A4 pattern in its LMP-2A first exon sequence). It is noteworthy that the BLV gp30 can transduce a signal in both a B and a T murine cell line.
In contrast, the B95 LMP-2A cytoplasmic domain can transduce only in a B cell line (Beaufils et al., 1993) . One possible explanation is the fact the non-pivotal interspacing amino acids can contribute to the specificity for distinct cytoplasmic ligands. This function of the ARAM interspacing amino acids has been demonstrated for transducing proteins associated with the B cell antigen receptor (Clark et al., 1992) . Similarly LMP-2 ARAM polymorphism could affect its specificity for cellular ligands and consequently the host cell range of various EBV strains. The identification of these natural occurring polymorphisms within the ARAM will facilitate further study on the effect of this sequence variation in in vitro assays of function.
